Immune System Suppression With Alemtuzumab and Tacrolimus in Liver Transplantation Patients - No Study Results Posted

Immune System Suppression With Alemtuzumab and Tacrolimus in Liver Transplantation Patients (TILT)

This study has been completed.

Study NCT00105235 Information provided by National Institute of Allergy and Infectious Diseases (NIAID)

First Received: March 10, 2005 Last Updated: September 8, 2011 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Study Completion Date:	March 2011
Primary Completion Date:	March 2007 (Final data collection date for primary outcome measure)